Adirondack Trust Company’s Outset Medical OM Stock Holding History

Adirondack Trust Company’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77	Hold	18	–	–	﹤0.01%	557
2026 Q1	$68	Hold	18	–	–	﹤0.01%	543
2025 Q4	$66	Hold	18	–	–	﹤0.01%	534
2025 Q3	$254	Hold	18	–	–	﹤0.01%	506
2025 Q2	$345	Hold	18	–	–	﹤0.01%	473
2025 Q1	$199	Sell	18 -1	-5%	-$12	﹤0.01%	473
2024 Q4	$308	Hold	19	–	–	﹤0.01%	478
2024 Q3	$187	Hold	19	–	–	﹤0.01%	486
2024 Q2	$1.08K	Hold	19	–	–	﹤0.01%	475
2024 Q1	$621	Hold	19	–	–	﹤0.01%	490
2023 Q4	$882	Hold	19	–	–	﹤0.01%	481
2023 Q3	$3.05K	Hold	19	–	–	﹤0.01%	438
2023 Q2	$5.76K	Hold	19	–	–	﹤0.01%	380
2023 Q1	$5.15K	Hold	19	–	–	﹤0.01%	398
2022 Q4	$7.23K	Hold	19	–	–	﹤0.01%	362
2022 Q3	$4K	Hold	19	–	–	﹤0.01%	416
2022 Q2	$4K	Hold	19	–	–	﹤0.01%	395
2022 Q1	$13K	Buy	19 +12	+171%	+$7.22K	0.01%	291
2021 Q4	$5K	Buy	+7	New	+$5.18K	﹤0.01%	359

Other funds holding OM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Adirondack Trust Company's OM Position: Q2 2026 in Review

Adirondack Trust Company held its Outset Medical (OM) position steady in Q2 2026 at 18 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Adirondack Trust Company first reported a position in OM in Q4 2021 and has held it in 19 quarters since. The position peaked at $13K in Q1 2022. 7 funds tracked by Wall St. Rank hold OM as of Q2 2026.

Adirondack Trust Company held 18 shares of Outset Medical worth $77 as of Q2 2026.
Adirondack Trust Company left its Outset Medical share count unchanged in Q2 2026.
Outset Medical made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #557 holding.
Adirondack Trust Company first reported a position in Outset Medical in Q4 2021 and has held it in 19 quarters since.
Adirondack Trust Company's Outset Medical position peaked at $13K in Q1 2022.
7 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.